Safety of cyclin-dependent kinase4/6 inhibitor combined with palliative radiotherapy in patients with metastatic breast cancer

Safety of cyclin-dependent kinase4/6 inhibitor combined with palliative radiotherapy in patients with metastatic breast cancer

Introduction: Cyclin-dependent kinase (CDK)4/6 inhibitor is a first-line therapy for metastatic ER+/HER2-breast cancer. However, there are limited data on safety of combined radiotherapy (RT) and CDK4/6 inhibition. Methods: We conducted a retrospective study of women with metastatic breast cancer wh...

Full description

Bibliographic Details
Main Authors:	Kristine N. Kim, Payal Shah, Amy Clark, Gary M. Freedman, Sana Dastgheyb, Andrew R. Barsky, Alexandra D. Dreyfuss, Neil K. Taunk
Format:	Article
Language:	English
Published:	Elsevier 2021-12-01
Series:	Breast
Subjects:	CDK4/6 inhibitor Radiotherapy Palliation Metastatic breast cancer Safety
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977621004719

Similar Items

Enhanced toxicity with CDK 4/6 inhibitors and palliative radiotherapy: Non-consecutive case series and review of the literature
by: Steven David, et al.
Published: (2021-01-01)

Radiation Therapy in Metastatic Soft Tissue Sarcoma: From Palliation to Ablation
by: Nishant K. Shah, et al.
Published: (2021-09-01)

Management of Metastatic Disease in Campania (MAMETIC): An Observational Multicenter Retrospective and Prospective Trial on Palliative Radiotherapy in an Italian Region. Study Protocol
by: Di Franco R, et al.
Published: (2022-04-01)

Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot
by: Anna Lee, et al.
Published: (2021-07-01)

Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia
by: Jesús Fuentes-Antrás, et al.
Published: (2020-12-01)

Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer
by: Chun Ho Kyung, et al.
Published: (2011-05-01)

Factors Associated with Long-Term Prostate Cancer Survival after Palliative Radiotherapy to a Bone Metastasis and Contemporary Palliative Systemic Therapy: A Retrospective, Population-Based Study
by: Bindu Venugopal, et al.
Published: (2023-06-01)

The Effectiveness of PAlliative Split COurse RAdiotherapy (PASCORA) Regimen in Non-metastatic Head and Neck Cancer Patients who are Treated with Palliative Intent- A Retrospective Single Centre Study
by: Umesh Velu, et al.
Published: (2022-12-01)

Palliative radiotherapy near the end of life
by: Susan Y. Wu, et al.
Published: (2019-03-01)

Palliative radiotherapy for gastric cancer: Is there a dose relationship between bleeding response and radiotherapy?
by: Gustavo Arruda Viani, et al.
Published: (2020-09-01)

Prognostication in palliative radiotherapy—ProPaRT: Accuracy of prognostic scores
by: Marco Maltoni, et al.
Published: (2022-08-01)

Breast metastasis from primary lung cancer and its association with ablative radiotherapy: A case report
by: Matthew E. Volpini, et al.
Published: (2023-09-01)

Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life
by: Sebastian M. Christ, et al.
Published: (2022-05-01)

Efficacy and Toxicity of Hypofractionated Palliative Radiotherapy for Breast Cancer Patients with Skin Invasion
by: Talha Maqsood, et al.
Published: (2023-08-01)

Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy
by: Dirk Rades, et al.
Published: (2022-08-01)

External Beam Radiotherapy for Dysphagia Palliation in Advanced Esophageal Cancer: A Prospective Study
by: Abhinandan Das, et al.
Published: (2023-11-01)

Palliative radiotherapy in symptomatic locally advanced gastric cancer: A phase II trial
by: Jeremy Tey, et al.
Published: (2019-04-01)

The development, implementation and evaluation of an outpatient palliative radiotherapy programme
by: C.V. Monique Vahedi Nikbakht-Van de Sande, et al.
Published: (2009-12-01)

The development, implementation and evaluation of an outpatient palliative radiotherapy programme
by: C.V. Monique Vahedi Nikbakht-Van de Sande, et al.
Published: (2009-12-01)

Symptom palliation of hypofractionated radiotherapy for patients with incurable inflammatory breast cancer
by: Hoon Sik Choi, et al.
Published: (2019-06-01)

Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy
by: Keiko Akahane, et al.
Published: (2020-05-01)

The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysisResearch in context
by: Luca Mastrantoni, et al.
Published: (2023-02-01)

Imidazole-4-N-acetamide Derivatives as a Novel Scaffold for Selective Targeting of Cyclin Dependent Kinases
by: Polina Rusina, et al.
Published: (2023-07-01)

Evaluation of the clinical feasibility of cone-beam computed tomography guided online adaption for simulation-free palliative radiotherapy
by: Alannah Kejda, et al.
Published: (2023-10-01)

An easy tool to predict survival in patients with bone metastatic lung cancer treated with palliative radiotherapy
by: Kenji Makita, et al.
Published: (2023-07-01)

Relationships between family physicians’ referral for palliative radiotherapy, knowledge of indications for radiotherapy, and prior training: a survey of rural and urban family physicians
by: Olson Robert A, et al.
Published: (2012-05-01)

The Palliative Care in the Metastatic Spinal Tumors. A Systematic Review on the Radiotherapy and Surgical Perspective
by: Giuseppe Roberto Giammalva, et al.
Published: (2022-04-01)

Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer
by: Xueting Li, et al.
Published: (2024-01-01)

Reduction of oesophageal toxicity with VMAT dose-sparing radiotherapy in thoracic metastatic spinal cord compression: A feasibility study
by: Vanja Remberg Gram, et al.
Published: (2022-09-01)

Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto Rico
by: Valerie Quiñones-Avila, et al.
Published: (2021-08-01)

Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment
by: Ni Made Pitri Susanti, et al.
Published: (2021-07-01)

Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer
by: Yun Hee Lee, et al.
Published: (2017-08-01)

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era
by: Ryan S. Youland, et al.
Published: (2017-10-01)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
by: Michael Laursen, et al.
Published: (2018-06-01)

Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer
by: Jing Xu, et al.
Published: (2019-12-01)

Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study
by: Taro Shibuki, et al.
Published: (2023-10-01)

Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
by: Shaian Tavakolian, et al.
Published: (2020-05-01)

The Clinicopathological Significance of the Cyclin D1/E1–Cyclin-Dependent Kinase (CDK2/4/6)–Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers
by: Ayat Lashen, et al.
Published: (2024-04-01)

Palliative Radiotherapy for Leptomeningeal Carcinomatosis–Analysis of Outcome, Prognostic Factors, and Symptom Response
by: Rami A. El Shafie, et al.
Published: (2019-01-01)

Considerations on surgery invasiveness and response and toxicity patterns in classic palliative radiotherapy for acrometastases of the hand: a hint for a potential role of stereotactic body radiation therapy? A case report and literature review
by: Gianluca Ferini, et al.
Published: (2023-06-01)